It’s an attempt to push back against social progress.
The FDA’s controversial approval of a Biogen drug for Alzheimer’s disease could blunt future R&D, experts warn.
BuzzFeed is smaller than it thought it was going to be but it thinks it’s big enough to sell shares to the public this fall.
How we all failed Britney Spears.
Workers are quitting their jobs. But are they getting better ones?
The expanded child tax credit should be easy to get — and permanent.
SCOTUS is forced to clean up a $124 billion mess of its own making.
Chrome’s third-party cookie ban has been delayed for another year.